A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

Exelixis' most important product should continue driving strong financial results through the end of the decade. A decade ago ...

Doctors at the University of California - San Diego have discovered a new marker of one of America's deadliest cancers - ...

The young bride had to postpone her wedding after her diagnosis. She's part of a "significant rise" in people in their 20s, ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of ...

Colorectal cancer rates are rising sharply among people age 50 and younger, alarming oncologists, public health experts and health systems. Researchers say the causes are likely multifaceted and still ...

An analysis of SEER registry data published in 2003 revealed for the first time a troubling rise in colorectal cancer among young adults in the United States.Since then, most published papers and ...

Of all early-onset cancers in the U.S., gastrointestinal cancers are increasing most rapidly, according to a review published July 17 in JAMA.  Defined as occurring in patients under the age of 50, ...

A new study over 10 years showed that colorectal cancers affecting adults under the age of 40 have increased by 3.4%. Dr. Darien Sutton breaks down all the data.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2025 and raised full-year guidance.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Raises Full-Year Guidance Financial results from Operations for second quarter 2025 versus second quarter 2024: Revenue: $3.53 billion versus $3.22 billion ...